Sedation and analgesia in critically ill neurologic patients

Journal of Pharmacy Practice

Volumn 23, Issue 5, 2010, Pages 455-469

  Makii, Jason M ^a   Mirski, Marek A ^b   Lewin, John J ^b  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^b DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

analgesia; anxiolysis; delirium; intensive care unit; neurologic; sedation

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE DERIVATIVE; DEXMEDETOMIDINE; DIAZEPAM; DROPERIDOL; FENTANYL; FOSPROPOFOL; HALOPERIDOL; LORAZEPAM; MIDAZOLAM; MORPHINE SULFATE; NARCOTIC AGENT; OLANZAPINE; PENTOBARBITAL; PHENOBARBITAL; PROPOFOL; QUETIAPINE; REMIFENTANIL; RISPERIDONE; THIOPENTAL;

ANALGESIA; ANXIETY; CRITICALLY ILL PATIENT; DELIRIUM; HUMAN; INTENSIVE CARE UNIT; NEUROLOGIC EXAMINATION; PAIN; REVIEW; SEDATION; TRANQUILIZING ACTIVITY;

EID: 78649947909     PISSN: 08971900     EISSN: 15311937     Source Type: Journal    
DOI: 10.1177/0897190010372339     Document Type: Review

References (78)

1. Phillips DM JCAHO pain management standards are unveiled. Joint Commission on Accreditation of Healthcare Organizations. JAMA. 2000 ; 284 (4). 428-429.
2. Kress JP, Pohlman AS, O'Connor MF, et al. Daily interruption of sedative infusions in critically ill patients undergoing mechanical ventilation. N Engl J Med. 2000 ; 342 (20). 1471-1477.
3. Hogarth DK, Hall J. Management of sedation in mechanically ventilated patients. Curr Opin Crit Care. 2004 ; 10 (1). 40-46.
4. Mirski MA, Muffelman B., Ulatowski JA, et al. Sedation for the critically ill neurologic patient. Crit Care Med. 1995 ; 23 (12). 2038-2053.
5. Pre-publication Standards | Joint Commission [Internet]. Available at: www.jointcommission.org. Accessed November 4, 2009.
6. Payen JF, Bru O., Bosson JL, et al. Assessing pain in critically ill sedated patients by using a behavioral pain scale. Crit Care Med. 2001 ; 29 (12). 2258-2263.
7. Mirski MA, Lewin JJ Sedation and pain management in acute neurological disease. Semin Neurol. 2008 ; 28 (5). 611-630.
8. Morad AH, Winters BD, Yaster M., et al. Efficacy of intravenous patient-controlled analgesia after supratentorial intracranial surgery: a prospective randomized controlled trial. Clinical article. J Neurosurg. 2009 ; 111 (2). 343-350.
9. Kwentus JA, Kirshner H. Chapter 14. Delirium, dementia, and amnestic syndromes. In: Ebert MH, Loosen PT, Nurcombe B, Leckman JF, eds. Current Diagnosis & Treatment: Psychiatry. 2nd ed. New York, NY: McGraw-Hill Companies, Inc ; 2008.
10. Ely EW, Siegel MD, Inouye SK Delirium in the intensive care unit: an under-recognized syndrome of organ dysfunction. Semin Respir Crit Care Med. 2001 ; 22 (2). 115-126.
11. Thomason JW, Shintani A., Peterson JF, et al. Intensive care unit delirium is an independent predictor of longer hospital stay: a prospective analysis of 261 non-ventilated patients. Crit Care. 2005 ; 9 (4). R375 - R381.
12. Peterson JF, Pun BT, Dittus RS, et al. Delirium and its motoric subtypes: A study of 614 critically ill patients. J Am Geriatr Soc. 2006 ; 54 (3). 479-484.
13. Jacobi J., Fraser GL, Coursin DB, et al. Clinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adult. Crit Care Med. 2002 ; 30 (1). 119-141. (Pubitemid 34112188)
14. Lonergan E., Britton AM, Luxenberg J., et al. Antipsychotics for delirium. Cochrane Database Syst Rev. 2007 ;(2). CD005594.
15. Citerio G., Cormio M. Sedation in neurointensive care: advances in understanding and practice. Curr Opin Crit Care. 2003 ; 9 (2). 120-126.
16. Li D., Puntillo K., Miaskowski C. A review of objective pain measures for use with critical care adult patients unable to self-report. J Pain. 2008 ; 9 (1). 2-10.
17. Mateo OM, Krenzischek DA A pilot study to assess the relationship between behavioral manifestations and self-report of pain in postanesthesia care unit patients. J Post Anesth Nurs. 1992 ; 7 (1). 15-21.
18. Odhner M., Wegman D., Freeland N., et al. Assessing pain control in nonverbal critically ill adults. Dimens Crit Care Nurs. 2003 ; 22 (6). 260-267.
19. Puntillo KA, Miaskowski C., Kehrle K., et al. Relationship between behavioral and physiological indicators of pain, critical care patients' self-reports of pain, and opioid administration. Crit Care Med. 1997 ; 25 (7). 1159-1166.
20. Ramsay MA, Savege TM, Simpson BR, Goodwin R. Controlled sedation with alphaxalone-alphadolone. Br Med J. 1974 ; 2 (5920). 656-659.
21. Riker RR, Picard JT, Fraser GL Prospective evaluation of the Sedation-Agitation Scale for adult critically ill patients. Crit Care Med. 1999 ; 27 (7). 1325-1329.
22. Devlin JW, Boleski G., Mlynarek M., et al. Motor activity assessment scale: A valid and reliable sedation scale for use with mechanically ventilated patients in an adult surgical intensive care unit. Crit Care Med. 1999 ; 27 (7). 1271-1275.
23. Ely EW, Truman B., Shintani A., et al. Monitoring sedation status over time in ICU patients: reliability and validity of the Richmond Agitation-Sedation Scale (RASS). JAMA. 2003 ; 289 (22). 2983-2991.
24. De Jonghe B., Cook D., Griffith L., et al. Adaptation to the intensive care environment (ATICE): development and validation of a new sedation assessment instrument. Crit Care Med. 2003 ; 31 (9). 2344-2354.
25. Avripas MB, Smythe MA, Carr A., et al. Development of an intensive care unit bedside sedation scale. Ann Pharmacother. 2001 ; 35 (2). 262-263.
26. de Lemos J., Tweeddale M., Chittock D. Measuring quality of sedation in adult mechanically ventilated critically ill patients: the Vancouver Interaction and Calmness Scale. Sedation Focus Group. J Clin Epidemiol. 2000 ; 53 (9). 908-919.
27. Weinert C., McFarland L. The state of intubated ICU patients: development of a two-dimensional sedation rating scale for critically ill adults. Chest. 2004 ; 126 (6). 1883-1890.
28. Brook AD, Ahrens TS, Schaiff R., et al. Effect of a nursing-implemented sedation protocol on the duration of mechanical ventilation. Crit Care Med. 1999 ; 27 (12). 2609-2615.
29. Hart RP, Levenson JL, Sessler CN, et al. Validation of a cognitive test for delirium in medical ICU patients. Psychosomatics. 1996 ; 37 (6). 533-546.
30. Hart RP, Best AM, Sessler CN, et al. Abbreviated cognitive test for delirium. J Psychosom Res. 1997 ; 43 (4). 417-423.
31. Ely EW, Inouye SK, Bernard GR, et al. Delirium in mechanically ventilated patients: Validity and reliability of the confusion assessment method for the intensive care unit (CAM-ICU). JAMA. 2001 ; 286 (21). 2703-2710.
32. Bergeron N., Dubois MJ, Dumont M., et al. Intensive care delirium screening checklist: evaluation of a new screening tool. Intensive Care Med. 2001 ; 27 (5). 859-864.
33. Neelon VJ, Champagne MT, Carlson JR, et al. The NEECHAM confusion scale: construction, validation, and clinical testing. Nurs Res. 1996 ; 45 (6). 324-330.
34. Otter H., Martin J., Basell K., et al. Validity and reliability of the DDS for severity of delirium in the ICU. Neurocrit Care. 2005 ; 2 (2). 150-158.
35. Gutstein HB, Akil H. Chapter 21. Opioid analgesics. In: Brunton LL, Lazo JS, Parker KL, eds. Goodman & Gilman's the Pharmacological Basis of Therapeutics. 11th ed. New York, NY: McGraw-Hill Companies, Inc ; 2006.
36. Albanese J., Viviand X., Potie F., et al. Sufentanil, fentanyl, and alfentanil in head trauma patients: a study on cerebral hemodynamics. Crit Care Med. 1999 ; 27 (2). 407-411.
37. Rao TL, Mummaneni N., El-Etr AA Convulsions: an unusual response to intravenous fentanyl administration. Anesth Analg. 1982 ; 61 (12). 1020-1021.
38. De Conno F., Caraceni A., Martini C., et al. Hyperalgesia and myoclonus with intrathecal infusion of high-dose morphine. Pain. 1991 ; 47 (3). 337-339.
39. Flacke JW, Flacke WE, Bloor BC, et al. Histamine release by four narcotics: a double-blind study in humans. Anesth Analg. 1987 ; 66 (8). 723-730.
40. Mather LE Clinical pharmacokinetics of fentanyl and its newer derivatives. Clin Pharmacokinet. 1983 ; 8 (5). 422-446.
41. Fentanyl Injection [package insert]. Lake Forest, IL: Hospira Inc ; 2003.
42. Dahaba AA, Grabner T., Rehak PH, et al. Remifentanil versus morphine analgesia and sedation for mechanically ventilated critically ill patients: a randomized double blind study. Anesthesiology. 2004 ; 101 (3). 640-646.
43. Leone M., Albanese J., Viviand X., et al. The effects of remifentanil on endotracheal suctioning-induced increases in intracranial pressure in head-injured patients. Anesth Analg. 2004 ; 99 (4). 1193-1198, table of contents.
44. Charney DS, Mihic SJ, Harris RA Chapter 16. Hypnotics and sedative. In: Brunton LL, Lazo JS, Parker KL, eds. Goodman & Gilman's the Pharmacological Basis of Therapeutics. 11th ed. New York, NY: McGraw-Hill Companies, Inc ; 2006.
45. Sanchez-Izquierdo-Riera JA, Caballero-Cubedo RE, Perez-Vela JL, et al. Propofol versus midazolam: safety and efficacy for sedating the severe trauma patient. Anesth Analg. 1998 ; 86 (6). 1219-1224.
46. Forster A., Juge O., Morel D. Effects of midazolam on cerebral hemodynamics and cerebral vasomotor responsiveness to carbon dioxide. J Cereb Blood Flow Metab. 1983 ; 3 (2). 246-249.
47. Pandharipande P., Shintani A., Peterson J., et al. Lorazepam is an independent risk factor for transitioning to delirium in intensive care unit patients. Anesthesiology. 2006 ; 104 (1). 21-26.
48. Yahwak JA, Riker RR, Fraser GL, et al. Determination of a lorazepam dose threshold for using the osmol gap to monitor for propylene glycol toxicity. Pharmacotherapy. 2008 ; 28 (8). 984-991.
49. Fountain NB, Adams RE Midazolam treatment of acute and refractory status epilepticus. Clin Neuropharmacol. 1999 ; 22 (5). 261-267.
50. Dobrydnjov I., Axelsson K., Samarutel J., et al. Postoperative pain relief following intrathecal bupivacaine combined with intrathecal or oral clonidine. Acta Anaesthesiol Scand. 2002 ; 46 (7). 806-814.
51. Iskandar H., Guillaume E., Dixmerias F., et al. The enhancement of sensory blockade by clonidine selectively added to mepivacaine after midhumeral block. Anesth Analg. 2001 ; 93 (3). 771-775.
52. Venn RM, Grounds RM Comparison between dexmedetomidine and propofol for sedation in the intensive care unit: Patient and clinician perceptions. Br J Anaesth. 2001 ; 87 (5). 684-690.
53. Mirski MA, Lewin JJ, LeDroux S., et al. Improvement in cognition during continuous sedation in critically ill patients - The acute neurological ICU sedation trial (ANIST). Intensive Care Med. epub 8 Apr 2010.
54. Khan ZP, Munday IT, Jones RM, et al. Effects of dexmedetomidine on isoflurane requirements in healthy volunteers. 1. Pharmacodynamic and pharmacokinetic interactions. Br J Anaesth. 1999 ; 83 (1). 372-380.
55. Tulen JH, van de Wetering BJ, Kruijk MP, et al. Cardiovascular, neuroendocrine, and sedative responses to four graded doses of clonidine in a placebo-controlled study. Biol Psychiatry. 1992 ; 32 (6). 485-500.
56. Lenhardt R., Orhan-Sungur M., Komatsu R., et al. Suppression of shivering during hypothermia using a novel drug combination in healthy volunteers. Anesthesiology. 2009 ; 111 (1). 110-115.
57. Goddeau RP Jr, Silverman SB, Sims JR Dexmedetomidine for the treatment of paroxysmal autonomic instability with dystonia. Neurocrit Care. 2007 ; 7 (3). 217-220.
58. Pandharipande PP, Pun BT, Herr DL, et al. Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients: the MENDS randomized controlled trial. JAMA. 2007 ; 298 (22). 2644-2653.
59. Riker RR, Shehabi Y., Bokesch PM, et al. Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial. JAMA. 2009 ; 301 (5). 489-499.
60. Szumita PM, Baroletti SA, Anger KE, et al. Sedation and analgesia in the intensive care unit: evaluating the role of dexmedetomidine. Am J Health Syst Pharm. 2007 ; 64 (1). 37-44.
61. ter Minassian A., Beydon L., Decq P., et al. Changes in cerebral hemodynamics after a single dose of clonidine in severely head-injured patients. Anesth Analg. 1997 ; 84 (1). 127-132.
62. Aryan HE, Box KW, Ibrahim D., et al. Safety and efficacy of dexmedetomidine in neurosurgical patients. Brain Inj. 2006 ; 20 (8). 791-798.
63. Talke P., Richardson CA, Scheinin M., et al. Postoperative pharmacokinetics and sympatholytic effects of dexmedetomidine. Anesth Analg. 1997 ; 85 (5). 1136-1142.
64. Baldessarini RJ, Tarazi FI Chapter 18. Pharmacotherapy of psychosis and mania. In: Brunton LL, Lazo JS, Parker KL, eds. Goodman & Gilman's the Pharmacological Basis of Therapeutics. 11th ed. New York, NY: McGraw-Hill Companies, Inc ; 2006.
65. Misfeldt BB, Jorgensen PB, Spotoft H., et al. The effects of droperidol and fentanyl on intracranial pressure and cerebral perfusion pressure in neurosurgical patients. Br J Anaesth. 1976 ; 48 (10). 963-968.
66. Lischke V., Behne M., Doelken P., et al. Droperidol causes a dose-dependent prolongation of the QT interval. Anesth Analg. 1994 ; 79 (5). 983-986.
67. Skrobik YK, Bergeron N., Dumont M., et al. Olanzapine vs haloperidol: treating delirium in a critical care setting. Intensive Care Med. 2004 ; 30 (3). 444-449.
68. Schwartz TL, Masand PS Treatment of delirium with quetiapine. Prim Care Companion J Clin Psychiatry. 2000 ; 2 (1). 10-12.
69. Devlin JW, Roberts RJ, Fong JJ, et al. Efficacy and safety of quetiapine in critically ill patients with delirium: a prospective, multi-center, randomized, double-blind, placebo-controlled pilot study. Crit Care Med. 2010 ; 38 (2). 419-427.
70. Han CS, Kim YK A double-blind trial of risperidone and haloperidol for the treatment of delirium. Psychosomatics. 2004 ; 45 (4). 297-301.
71. Propofol Injection Emulsion [package insert]. Wilmington, DE: AstraZeneca Pharmaceuticals LP ; 2009.
72. Alkire MT, Haier RJ Correlating in vivo anaesthetic effects with ex vivo receptor density data supports a GABAergic mechanism of action for propofol, but not for isoflurane. Br J Anaesth. 2001 ; 86 (5). 618-626.
73. Tsuchiya H. Structure-specific membrane-fluidizing effect of propofol. Clin Exp Pharmacol Physiol. 2001 ; 28 (4). 292-299.
74. Moore GD, Walker AM, MacLaren R. Fospropofol: a new sedative-hypnotic agent for monitored anesthesia care. Ann Pharmacother. 2009 ; 43 (11). 1802-1808.
75. GPI 15715 for sedation in the intensive care unit (ICU) setting- Full Text View-ClinicalTrials.gov. http://clinicaltrials.gov/ct2/show/NCT00125398. January 30, 2010.
76. Swerdlow BN, Holley FO Intravenous anaesthetic agents. pharmacokinetic-pharmacodynamic relationships. Clin Pharmacokinet. 1987 ; 12 (2). 79-110.
77. Bratton SL, Chestnut RM, Ghajar J., et al. Guidelines for the management of severe traumatic brain injury. XI. Anesthetics, analgesics, and sedatives. J Neurotrauma. 2007 ; 24 (suppl 1). S71 - S76.
78. Meierkord H., Boon P., Engelsen B., et al. EFNS guideline on the management of status epilepticus in adults. Eur J Neurol. 2009 ; 17 (3). 348-355.